Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.73 |
| ▸ | MAPT | P10636 | 4/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.73 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.73 |
| ▸ | TSHR | P16473 | 2/20 | 0.73 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.73 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.73 |
| ▸ | SHBG | P04278 | 2/20 | 0.73 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.73 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.73 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.73 |
| ▸ | PGR | P06401 | 2/20 | 0.73 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | MEN1 | O00255 | 1/20 | 0.73 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6263255 | 1.00 | LMNA (0.73) | LMNACYP3A4ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL9402966 | 0.92 | LMNA (0.68) | LMNACYP3A4ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL9402961 | 0.92 | LMNA (0.68) | LMNACYP3A4ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL9402952 | 0.92 | LMNA (0.68) | LMNACYP3A4ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL8994186 | 0.90 | LMNA (0.68) | LMNACYP3A4ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL8994192 | 0.90 | LMNA (0.68) | LMNACYP3A4ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL8377385 | 0.88 | LMNA (0.64) | LMNACYP3A4ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL8377389 | 0.88 | LMNA (0.64) | LMNACYP3A4ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL27814910 | 0.87 | SRD5A2 (0.61) | LMNACYP3A4ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL516592 | 0.86 | LMNA (0.78) | LMNACYP3A4ALDH1A1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005075497-A1 | PROCESS FOR THE PREPARATION OF 17ß-SUBSTITUTED-3-OXO-4-AZA-5ALPHA-ANDROSTANE DERIVATIVES | RANBAXY LABORATORIES LIMITED (IN) | 2005-08-18 | — | — | WO | disclosed |
| EP-0858455-A4 | 4-OXA AND 4-THIA STEROIDS | MERCK & CO INC (US) | 2000-04-12 | — | — | EP | disclosed |
| US-5998464-A | 4-Oxa and 4-thia steroids | MERCK & CO., INC. (US) | 1999-12-07 | — | — | US | disclosed |
| US-5932559-A | Treatment of hyperandrogenic conditions | MERCK & CO., INC. (US) | 1999-08-03 | — | — | US | disclosed |
| EP-0858455-A1 | 4-OXA AND 4-THIA STEROIDS | Merck & Co., Inc. (US) | 1998-08-19 | — | — | EP | disclosed |
| US-5777134-A | 4-oxa and 4-thia steriods | MERCK & CO., INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5760025-A | ADMINISTERING TESTOSTERONE 5A-REDUCTASE INHIBITORS | SANKYO COMPANY, LIMITED (JP) | 1998-06-02 | — | — | US | disclosed |
| US-5756480-A | Treatment of hyperandrogenic conditions | MERCK & CO., INC. (US) | 1998-05-26 | — | — | US | disclosed |
| US-5717088-A | REACTING WITH A CYANOPHOSPHATE IN THE PRESENCE OF AN ALKALI METAL CYANIDE | SANKYO COMPANY, LIMITED (JP) | 1998-02-10 | — | — | US | disclosed |
| US-5698720-A | INTERMEDIATES FOR TESTOSTERONE 5-ALPHA-REDUCTASE INHIBITORS | SANKYO COMPANY, LIMITED (JP) | 1997-12-16 | — | — | US | disclosed |
| EP-0469548-B1 | 4-Amino-delta4-steroids and their use as 5alpha-reductase inhibitors | MERRELL PHARMA INC (US) | 1996-06-05 | — | — | EP | disclosed |
| EP-0469547-B1 | 4-Amino-delta4,6-steroids and their use as 5alpha-reductase inhibitors | MERRELL PHARMA INC (US) | 1996-05-15 | — | — | EP | disclosed |
| US-5436237-A | Reductase inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-07-25 | — | — | US | disclosed |
| US-5318961-A | Enzyme inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1994-06-07 | — | — | US | disclosed |
| EP-0567271-A2 | Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses | SANKYO COMPANY LIMITED (JP) | 1993-10-27 | — | — | EP | disclosed |
| US-5218110-A | 4-amino-Δ4 -steroids and their use as 5α-reductase inhibitors | MERRELL DOW PHARMACEUTICALS (US) | 1993-06-08 | — | — | US | disclosed |
| US-5189032-A | Blocking the formation of dihydroxytestosterone from testosterone | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-02-23 | — | — | US | disclosed |
| US-5130424-A | Acne, skin disorders, scandular disorders | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-07-14 | — | — | US | disclosed |
| US-5120840-A | Treatment of acne, baldness, seborrhea and female hirsutism | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-06-09 | — | — | US | disclosed |
| EP-0469547-A2 | 4-Amino-delta4,6-steroids and their use as 5alpha-reductase inhibitors | MERRELL PHARMACEUTICALS INC. (US) | 1992-02-05 | — | — | EP | disclosed |